1. Home
  2. UNII Search
  3. UNII FYS6T7F842

UNII FYS6T7F842

ADALIMUMAB

Table of Contents

  1. UNII Information
  2. UNII Synonyms and Mappings
  3. UNII Resources
  4. UNII Crossover to NDC Codes

UNII Information

Unique Ingredient Identifier: FYS6T7F842
The Unique Ingredient Identifier (UNII) is a unique alphanumeric code assigned to a specific substance or ingredient by the FDA (Food and Drug Administration). UNII codes are non-proprietary, free, unique, unambiguous and nonsemantic. Each UNII code consists of 10 characters with both letters and numbers. The first two characters represent the source of the substance while the remaining eight characters represent the specific substance. UNII codes are primarily used to identify and track substances in several drug databases and regulatory documents related to drugs, biologics, and medical devices.
Formula: 7860
Molecular Formula, total atoms represented as a molecular structure in a UNII description.
Preferred Substance Name: ADALIMUMAB
The Preferred Substance Name (PSN) is the official or preferred name of a substance or ingredient. The preferred name provides a standardized and consistent name for each substance is used in the UNII code system. The preferred name may differ from other names also commonly used to refer the same substance. The PSN is usually the name used by regulatory agencies like the FDA.
InChIKey: NN-74
The InChIKey to a unique identifier for a specific substance or ingredient that is based on its molecular structure. InChIKey stands for International Chemical Identifier Key and is a fixed-length string created from the IUPAC International Chemical Identifier (InChI). The InChIKey is useful in drug development and chemical analysis, where the molecular structure of a substance is an important factor in determining its properties and effects.
Registry Number: 331731-18-1
The Registry Number is the unique numerical identifiers assigned to a substance or ingredient by the Chemical Abstracts Service (CAS). The CAS registry number is a used and recognized standard identifier by many industries and regulatory agencies. The Registry Number facilitates cross-referencing substances between different databases that may use different naming conventions or identifiers.
NCI Thesaurus Concept Code: C65216
The NCI Thesaurus give reference terminology for many systems. The code includes vocabulary for clinical care, translational research, basic research, public information and administrative activities.
UNII to RxNorm Crosswalk: 327361 (RXCUI)
The RxNorm Ingredient Concept Code is the numeric code assigned to a specific substance or ingredient by the National Library of Medicine's RxNorm system. By including the RxNorm code in the UNII code system it is possible to crossover UNII codes to RxNom.
Substance Type: INGREDIENT SUBSTANCE
The International Organization for Standardization - ISO 11238 substance type is used as a data element in the UNII code system to provide additional information about the type of substance being identified.

UNII Synonyms and Mappings

The following synonyms and mappings provide alternative ways to refer to the same substance or ingredient. Synonyms may include different names or spellings, alternate chemical names, trade names, or other common names.

  • ABP-501 - Code
  • ABRILADA - Brand/Trade Name
  • ADALIMUMAB - Name identified as having official status
  • ADALIMUMAB (ABBVIE) - Common Name
  • ADALIMUMAB (GENETICAL RECOMBINATION) - Common Name
  • ADALIMUMAB (GENETICAL RECOMBINATION) [JAN] - Common Name
  • ADALIMUMAB (HUMIRA) - Common Name
  • ADALIMUMAB [EMA EPAR] - Common Name
  • ADALIMUMAB [HSDB] - Common Name
  • ADALIMUMAB [INN] - Common Name
  • ADALIMUMAB [JAN] - Common Name
  • ADALIMUMAB [MART.] - Common Name
  • ADALIMUMAB [MI] - Common Name
  • ADALIMUMAB [PURPLE BOOK CDER] - Common Name
  • ADALIMUMAB [USAN] - Common Name
  • ADALIMUMAB [VANDF] - Common Name
  • ADALIMUMAB [WHO-DD] - Common Name
  • ADALIMUMAB ADAZ [WHO-DD] - Common Name
  • ADALIMUMAB ADBM [WHO-DD] - Common Name
  • ADALIMUMAB AFZB [WHO-DD] - Common Name
  • ADALIMUMAB AQVH [WHO-DD] - Common Name
  • ADALIMUMAB ATTO [WHO-DD] - Common Name
  • ADALIMUMAB BETA - Name identified as having official status
  • ADALIMUMAB BETA [INN] - Common Name
  • ADALIMUMAB BIOSIMILAR (ALVOTECH) - Common Name
  • ADALIMUMAB BIOSIMILAR (AMGEN) - Common Name
  • ADALIMUMAB BIOSIMILAR (AVT02) - Common Name
  • ADALIMUMAB BIOSIMILAR (BOEHRINGER INGELHEIM) - Common Name
  • ADALIMUMAB BIOSIMILAR (CELLTRION) - Common Name
  • ADALIMUMAB BIOSIMILAR (COHERUS BIOSCIENCES) - Common Name
  • ADALIMUMAB BIOSIMILAR (CT-P17) - Common Name
  • ADALIMUMAB BIOSIMILAR (FKB-327) - Code
  • ADALIMUMAB BIOSIMILAR (FUJIFILM KYOWA KIRIN BIOLOGICS) - Common Name
  • ADALIMUMAB BIOSIMILAR (MSB11022) - Common Name
  • ADALIMUMAB BIOSIMILAR (MYLAN) - Common Name
  • ADALIMUMAB BIOSIMILAR (PF-06410293) - Common Name
  • ADALIMUMAB BIOSIMILAR (PFIZER) - Common Name
  • ADALIMUMAB BIOSIMILAR (SAMSUNG BIOEPIS) - Common Name
  • ADALIMUMAB BIOSIMILAR (SANDOZ) - Common Name
  • ADALIMUMAB BIOSIMILAR (YUSIMRY) - Common Name
  • ADALIMUMAB BIOSIMILAR (ZRC-3197) - Common Name
  • ADALIMUMAB BWWD [WHO-DD] - Common Name
  • ADALIMUMAB FKJP [WHO-DD] - Common Name
  • ADALIMUMAB, LICENSE HOLDER UNSPECIFIED - Common Name
  • ADALIMUMAB-AACF - Name identified as having official status
  • ADALIMUMAB-AATY - Name identified as having official status
  • ADALIMUMAB-ADAZ - Name identified as having official status
  • ADALIMUMAB-ADAZ [PURPLE BOOK CDER] - Common Name
  • ADALIMUMAB-ADBM - Name identified as having official status
  • ADALIMUMAB-ADBM [PURPLE BOOK CDER] - Common Name
  • ADALIMUMAB-AFZB - Name identified as having official status
  • ADALIMUMAB-AQVH - Name identified as having official status
  • ADALIMUMAB-ATTO - Name identified as having official status
  • ADALIMUMAB-ATTO [PURPLE BOOK CDER] - Common Name
  • ADALIMUMAB-BWWD - Name identified as having official status
  • ADALIMUMAB-FKJP - Name identified as having official status
  • AMJEVITA - Brand/Trade Name
  • AMSPARITY - Brand/Trade Name
  • AVT02 - Common Name
  • AVT-02 - Code
  • BCD-057 - Common Name
  • BI 695501 [WHO-DD] - Common Name
  • BI695501 - Code
  • BI-695501 - Code
  • CHS-1420 - Common Name
  • CTP17 - Code
  • CT-P17 - Code
  • CYLTEZO - Common Name
  • D2E7 - Code
  • D3E7 - Code
  • EXEMPTIA - Brand/Trade Name
  • FKB-327 - Code
  • GP2017 - Code
  • GP-2017 - Code
  • HADLIMA - Brand/Trade Name
  • HULIO - Brand/Trade Name
  • HUMIRA - Brand/Trade Name
  • HYRIMOZ - Brand/Trade Name
  • IDACIO - Brand/Trade Name
  • IMMUNOGLOBULIN G1, ANTI-(HUMAN TUMOR NECROSIS FACTOR) (HUMAN MONOCLONAL D2E7 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL D2E7 LIGHT CHAIN, DIMER - Common Name
  • IMMUNOGLOBULIN G1, ANTI-(HUMAN TUMOR NECROSIS FACTOR) (HUMAN MONOCLONAL D2E7 HEAVY CHAIN), DISULPHIDE WITH HUMAN MONOCLONAL D2E7 LIGHT CHAIN, DIMER - Common Name
  • LBAL - Common Name
  • LU200134 - Code
  • LU-200134 - Code
  • M923 - Code
  • M-923 - Common Name
  • MSB11022 - Code
  • MSB-11022 - Code
  • ONS-3010 - Common Name
  • PF-06410293 - Code
  • SB5 - Code
  • SB-5 - Code
  • TRUDEXA - Brand/Trade Name
  • YUFLYMA - Brand/Trade Name
  • YUSIMRY - Brand/Trade Name
  • ZRC3197 - Code
  • ZRC-3197 - Code

UNII Resources

Common Chemistry
CAS Common Chemistry is an open community resource of the American Chemical Society for accessing chemical information. The chemical information in the CAS database is curated by expert scientists and includes information of common and frequently regulated chemicals and information applicable to high school and undergraduate chemistry classes.
Inxight Drugs
The National Center for Advancing Translational Sciences (NCATS) Inxight Drugs database has a comprehensive drug development information. The NCATS Inxight Drugs includes manually curated data provided by private companies and FDA. The database has marketing and regulatory status information, rigorous drug ingredient definitions, biological activity, clinical use, etc.
DailyMed Regulated Products
The National Library of Medicine DailyMed is a searchable database that includes the most recent product labeling information submitted to the FDA by private companies.
NCATS GSRS Full Record
The Global Substance Registration System (GSRS) was designed to facilitate global monitoring of human and animal medicinal, food, tobacco, and cosmetic products. GSRS includes unique substance identifiers consistent with the ISO 11238 standard.
NCI Thesaurus
NCI Thesaurus (NCIt) by the National Cancer Institute provides reference terminology for clinical care, translational and basic research, and public information and administrative activities.

UNII Crossover to NDC Codes

This unique ingredient identifier is listed as an ingredient or substance in the following products in the NDC directory:

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
0025-0325Proprietary Name: Abrilada Adalimumab-afzbKitPfizer Laboratories Div Pfizer IncACTIVE
0025-0328Proprietary Name: Abrilada Adalimumab-afzbKitPfizer Laboratories Div Pfizer IncACTIVE
0025-0333Proprietary Name: Abrilada Adalimumab-afzbKitPfizer Laboratories Div Pfizer IncACTIVE
0069-0325Proprietary Name: Abrilada Adalimumab-afzbKitPfizer Laboratories Div Pfizer IncACTIVE
0069-0328Proprietary Name: Abrilada Adalimumab-afzbKitPfizer Laboratories Div Pfizer IncACTIVE
0069-0333Proprietary Name: Abrilada Adalimumab-afzbKitPfizer Laboratories Div Pfizer IncACTIVE
0074-0067Proprietary Name: Humira AdalimumabKitAbbvie Inc.ACTIVE
0074-0124Proprietary Name: Humira AdalimumabKitAbbvie Inc.ACTIVE
0074-0243Proprietary Name: Humira AdalimumabKitAbbvie Inc.ACTIVE
0074-0554Proprietary Name: Humira AdalimumabKitAbbvie Inc.ACTIVE
0074-0616Proprietary Name: Humira AdalimumabKitAbbvie Inc.ACTIVE
0074-0817Proprietary Name: Humira AdalimumabKitAbbvie Inc.ACTIVE
0074-1539Proprietary Name: Humira AdalimumabKitAbbvie Inc.ACTIVE
0074-2540Proprietary Name: Humira AdalimumabKitAbbvie Inc.ACTIVE
0074-3799Proprietary Name: Humira AdalimumabKitAbbvie Inc.ACTIVE
0074-4339Proprietary Name: Humira AdalimumabKitAbbvie Inc.ACTIVE
0597-0370Proprietary Name: Cyltezo Adalimumab-adbmKitBoehringer Ingelheim Pharmaceuticals, Inc.ACTIVE
0597-0375Proprietary Name: Cyltezo Adalimumab-adbmKitBoehringer Ingelheim Pharmaceuticals, Inc.ACTIVE
0597-0400Proprietary Name: Cyltezo Adalimumab-adbmKitBoehringer Ingelheim Pharmaceuticals, Inc.ACTIVE
0597-0405Proprietary Name: Cyltezo Adalimumab-adbmKitBoehringer Ingelheim Pharmaceuticals, Inc.ACTIVE
0597-0545Proprietary Name: Adalimumab-adbm Adalimumab-adbmKitBoehringer Ingelheim Pharmaceuticals, Inc.ACTIVE
0597-0555Proprietary Name: Adalimumab-adbm Adalimumab-adbmKitBoehringer Ingelheim Pharmaceuticals, Inc.ACTIVE
0597-0585Proprietary Name: Adalimumab-adbm Adalimumab-adbmKitBoehringer Ingelheim Pharmaceuticals, Inc.ACTIVE
0597-0595Proprietary Name: Adalimumab-adbm Adalimumab-adbmKitBoehringer Ingelheim Pharmaceuticals, Inc.ACTIVE
49502-380Proprietary Name: Hulio AdalimumabKitMylan Specialty L.p.ACTIVE
49502-381Proprietary Name: Hulio AdalimumabKitMylan Specialty L.p.ACTIVE
49502-382Proprietary Name: Hulio AdalimumabKitMylan Specialty L.p.ACTIVE
49502-416Proprietary Name: Adalimumab AdalimumabKitMylan Specialty L.p.ACTIVE
49502-417Proprietary Name: Adalimumab AdalimumabKitMylan Specialty L.p.ACTIVE
49502-418Proprietary Name: Adalimumab AdalimumabKitMylan Specialty L.p.ACTIVE
50090-4487Proprietary Name: Humira AdalimumabKitA-s Medication SolutionsACTIVE
50090-6411Proprietary Name: Amjevita Adalimumab-attoInjectionSubcutaneousA-s Medication SolutionsACTIVE
50090-6428Proprietary Name: Amjevita Adalimumab-attoInjectionSubcutaneousA-s Medication SolutionsACTIVE
50090-6704Proprietary Name: Hadlima Adalimumab-bwwdSolutionSubcutaneousA-s Medication SolutionsACTIVE
50090-6705Proprietary Name: Hadlima Adalimumab-bwwdSolutionSubcutaneousA-s Medication SolutionsACTIVE
50090-6706Proprietary Name: Hadlima Adalimumab-bwwdSolutionSubcutaneousA-s Medication SolutionsACTIVE
50090-6707Proprietary Name: Hadlima Adalimumab-bwwdSolutionSubcutaneousA-s Medication SolutionsACTIVE
51407-834Proprietary Name: Adalimumab AdalimumabKitGolden State Medical Supply, Inc.ACTIVE
51407-835Proprietary Name: Adalimumab AdalimumabKitGolden State Medical Supply, Inc.ACTIVE
55513-400Proprietary Name: Amjevita Adalimumab-attoInjectionSubcutaneousAmgen IncACTIVE
55513-410Proprietary Name: Amjevita Adalimumab-attoInjectionSubcutaneousAmgen IncACTIVE
55513-411Proprietary Name: Amjevita Adalimumab-attoInjectionSubcutaneousAmgen IncACTIVE
61314-327Proprietary Name: Adalimumab Adalimumab-adazInjection, SolutionSubcutaneousSandoz Inc.ACTIVE
61314-454Proprietary Name: Hyrimoz Adalimumab-adazInjection, SolutionSubcutaneousSandoz IncACTIVE
61314-473Proprietary Name: Hyrimoz Adalimumab-adazInjection, SolutionSubcutaneousSandoz IncACTIVE
61314-476Proprietary Name: Hyrimoz Adalimumab-adazInjection, SolutionSubcutaneousSandoz IncACTIVE
61314-509Proprietary Name: Hyrimoz Adalimumab-adazInjection, SolutionSubcutaneousSandoz IncACTIVE
61314-517Proprietary Name: Hyrimoz Adalimumab-adazKitSandoz IncACTIVE
61314-531Proprietary Name: Hyrimoz Adalimumab-adazKitSandoz IncACTIVE
65219-554Proprietary Name: Idacio AdalimumabInjection, SolutionSubcutaneousFresenius Kabi Usa, LlcACTIVE
65219-556Proprietary Name: Idacio AdalimumabInjection, SolutionSubcutaneousFresenius Kabi Usa, LlcACTIVE
65219-612Proprietary Name: Adalimumab-aacf AdalimumabKitSubcutaneousFresenius Kabi Usa, LlcACTIVE
70114-210Proprietary Name: Yusimry Adalimumab-aqvhInjection, SolutionSubcutaneousCoherus Biosciences IncACTIVE
70114-220Proprietary Name: Yusimry Adalimumab-aqvhInjection, SolutionSubcutaneousCoherus Biosciences IncACTIVE
72511-400Proprietary Name: Amjevita Adalimumab-attoInjectionSubcutaneousAmgen Usa Inc.ACTIVE
72606-022Proprietary Name: Adalimumab Adalimumab-aatyInjectionSubcutaneousCelltrion Usa, Inc.ACTIVE
72606-030Proprietary Name: Yuflyma AdalimumabInjectionSubcutaneousCelltrion Usa, Inc.ACTIVE
72606-040Proprietary Name: Adalimumab Adalimumab-aatyInjectionSubcutaneousCelltrion Usa, Inc.ACTIVE
72606-041Proprietary Name: Adalimumab Adalimumab-aatyInjectionSubcutaneousCelltrion Usa, Inc.ACTIVE
78206-183Proprietary Name: Hadlima Adalimumab-bwwdSolutionSubcutaneousOrganon LlcACTIVE
78206-184Proprietary Name: Hadlima Adalimumab-bwwdSolutionSubcutaneousOrganon LlcACTIVE
78206-185Proprietary Name: Hadlima Adalimumab-bwwdSolutionSubcutaneousOrganon LlcACTIVE
78206-186Proprietary Name: Hadlima Adalimumab-bwwdSolutionSubcutaneousOrganon LlcACTIVE
78206-187Proprietary Name: Hadlima Adalimumab-bwwdSolutionSubcutaneousOrganon LlcACTIVE
83257-016Proprietary Name: Hulio Adalimumab-fkjpKitBiocon Biologics IncACTIVE
83257-017Proprietary Name: Hulio Adalimumab-fkjpKitBiocon Biologics IncACTIVE
83257-019Proprietary Name: Hulio Adalimumab-fkjpKitBiocon Biologics IncACTIVE
83457-100Proprietary Name: Hyrimoz Adalimumab-adazInjection, SolutionSubcutaneousCordavis LimitedACTIVE
83457-101Proprietary Name: Hyrimoz Adalimumab-adazInjection, SolutionSubcutaneousCordavis LimitedACTIVE
83457-102Proprietary Name: Hyrimoz Adalimumab-adazInjection, SolutionSubcutaneousCordavis LimitedACTIVE
83457-103Proprietary Name: Hyrimoz Adalimumab-adazInjection, SolutionSubcutaneousCordavis LimitedACTIVE